A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or ag
about
Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literaturePharmacological approaches to the challenge of treatment-resistant depressionVortioxetine: a New Treatment for Major Depressive Disorder.Major depressive disorder: mechanism-based prescribing for personalized medicineA Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder.Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.The effect of vortioxetine on overall patient functioning in patients with major depressive disorder.A randomized, double-blind, placebo-controlled 8-week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder.Vortioxetine: A multimodal antidepressant or another selective serotonin reuptake inhibitor?Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.Vortioxetine : a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder.Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder.Vortioxetine for depression in adults.The Effects of Newer Antidepressants on Occupational Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Evidence-based pharmacotherapy of treatment-resistant unipolar depression.Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder.The impact of antidepressant treatments on family functioning in adults with major depressive disorder: a post hoc comparison of vortioxetine and agomelatine.Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland.Cost-effectiveness of vortioxetine versus venlafaxine (extended release) in the treatment of major depressive disorder in South Korea.Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries.
P2860
Q26796436-F562EB88-88EC-42B1-8141-CCB3D01F9AD4Q26798241-F40F2472-A79A-4B93-BB30-C172687AB2DEQ34505568-D2859598-8A95-407F-AAE5-772FD0276CE1Q35284412-4769D497-B735-4128-9386-7723511E64A8Q35918242-5E716590-E5CA-4EA3-88F0-F47CE296D79CQ35918863-035EA5B7-9701-4B33-8B61-59ECE667EB9CQ37694366-1CA65C73-A1B7-4005-BCA8-815868B0072CQ38371388-7DDEE5F0-5186-47D4-9822-8D26FF6A4803Q38439748-8B983DE2-3ADB-45D2-B12B-802D5619391AQ38476909-05096805-4A42-48EB-916B-D3534DFDF83DQ38506798-131DCC40-3D9B-408A-8E29-6EF8E490D63BQ38543238-3A3FC7B3-8C34-40DC-A4ED-6528A9650E85Q38693309-393C3EFD-7134-44C5-8D45-9DE1383A7BE7Q38817431-6297488D-A470-452A-B9EF-B34B09021CA4Q39009865-88C4CE8B-486F-4353-B231-33956FF36336Q47657288-A72194CA-BAAB-4F35-B948-9D9349355E0CQ47950300-4374114D-4015-406B-9A47-92937A927147Q48038510-47F80466-BCE9-46A2-9FF3-E648B8912AAEQ48069160-B5A88641-D859-4789-AFBB-D623ACBD605CQ49384717-0DC1B6E6-0FD1-46F8-A2AC-7F00C0C585E8
P2860
A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or ag
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A randomised, double-blind stu ...... switched to vortioxetine or ag
@ast
A randomised, double-blind stu ...... switched to vortioxetine or ag
@en
A randomised, double-blind stu ...... switched to vortioxetine or ag
@nl
type
label
A randomised, double-blind stu ...... switched to vortioxetine or ag
@ast
A randomised, double-blind stu ...... switched to vortioxetine or ag
@en
A randomised, double-blind stu ...... switched to vortioxetine or ag
@nl
prefLabel
A randomised, double-blind stu ...... switched to vortioxetine or ag
@ast
A randomised, double-blind stu ...... switched to vortioxetine or ag
@en
A randomised, double-blind stu ...... switched to vortioxetine or ag
@nl
P2093
P2860
P356
P1476
A randomised, double-blind stu ...... switched to vortioxetine or ag
@en
P2093
Lars Häggström
Lis H Poulsen
Rebecca Z Nielsen
Stuart A Montgomery
P2860
P304
P356
10.1002/HUP.2424
P577
2014-09-01T00:00:00Z